Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 15 06 2020
revised: 20 08 2020
accepted: 08 10 2020
pubmed: 5 11 2020
medline: 16 1 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

Reactive aldehydes arise as by-products of metabolism and are normally cleared by multiple families of enzymes. We find that mice lacking two aldehyde detoxifying enzymes, mitochondrial ALDH2 and cytoplasmic ADH5, have greatly shortened lifespans and develop leukemia. Hematopoiesis is disrupted profoundly, with a reduction of hematopoietic stem cells and common lymphoid progenitors causing a severely depleted acquired immune system. We show that formaldehyde is a common substrate of ALDH2 and ADH5 and establish methods to quantify elevated blood formaldehyde and formaldehyde-DNA adducts in tissues. Bone-marrow-derived progenitors actively engage DNA repair but also imprint a formaldehyde-driven mutation signature similar to aging-associated human cancer mutation signatures. Furthermore, we identify analogous genetic defects in children causing a previously uncharacterized inherited bone marrow failure and pre-leukemic syndrome. Endogenous formaldehyde clearance alone is therefore critical for hematopoiesis and in limiting mutagenesis in somatic tissues.

Identifiants

pubmed: 33147438
pii: S1097-2765(20)30719-X
doi: 10.1016/j.molcel.2020.10.012
pmc: PMC7758861
pii:
doi:

Substances chimiques

Aldehydes 0
DNA Adducts 0
Formaldehyde 1HG84L3525
Adh5 protein, mouse EC 1.1.1.1
Alcohol Dehydrogenase EC 1.1.1.1
Aldehyde Dehydrogenase, Mitochondrial EC 1.2.1.3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

996-1012.e9

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00016/17
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0902418
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105178811
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : Cancer Research UK
ID : C60150/A23919
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : P42 ES005948
Pays : United States
Organisme : Medical Research Council
ID : MR/M008975/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 MRC Laboratory of Molecular Biology. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Biochim Biophys Acta. 1974 Jun 18;350(2):277-91
pubmed: 4152610
Curr Opin Cell Biol. 2015 Dec;37:49-60
pubmed: 26512453
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
PLoS Med. 2009 Mar 24;6(3):e50
pubmed: 19320537
Hum Genomics. 2011 May;5(4):283-303
pubmed: 21712190
Nat Rev Mol Cell Biol. 2016 Jun;17(6):337-49
pubmed: 27145721
Proc Natl Acad Sci U S A. 1974 Nov;71(11):4508-12
pubmed: 4140506
Nature. 2019 Oct;574(7779):532-537
pubmed: 31645730
Blood. 2013 Oct 31;122(18):3206-9
pubmed: 24037726
Nature. 2016 Oct 13;538(7624):260-264
pubmed: 27698416
Chem Res Toxicol. 2011 Feb 18;24(2):162-4
pubmed: 21222454
J Chromatogr B Biomed Sci Appl. 2001 Apr 5;753(2):253-7
pubmed: 11334338
Nature. 2020 Mar;579(7800):603-608
pubmed: 32132710
Mol Cell. 2015 Oct 1;60(1):177-88
pubmed: 26412304
Nucleic Acids Res. 2020 Feb 20;48(3):1013-1028
pubmed: 31350888
Nature. 2011 Jul 06;475(7354):53-8
pubmed: 21734703
Hematol Oncol Clin North Am. 2009 Apr;23(2):215-31
pubmed: 19327580
Toxicol Sci. 2013 May;133(1):1-12
pubmed: 23425604
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Mol Cell Biol. 1999 Jul;19(7):5166-9
pubmed: 10373565
J Hepatol. 2019 Nov;71(5):1000-1011
pubmed: 31279903
Nat Genet. 2015 Dec;47(12):1402-7
pubmed: 26551669
Nature. 2012 Sep 27;489(7417):571-5
pubmed: 22922648
Nature. 2013 Jan 17;493(7432):356-63
pubmed: 23325218
Exp Hematol. 2019 Oct;78:11-20
pubmed: 31513832
Asian Pac J Cancer Prev. 2001;2(2):99-107
pubmed: 12718640
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Annu Rev Pharmacol Toxicol. 2015;55:107-27
pubmed: 25292432
Blood. 2019 Mar 7;133(10):1071-1085
pubmed: 30670445
Toxicol Sci. 2015 Jul;146(1):170-82
pubmed: 25904104
Nat Genet. 2016 Jun;48(6):600-606
pubmed: 27111033
Int J Hematol. 2007 May;85(4):354-61
pubmed: 17483082
Nat Struct Mol Biol. 2011 Nov 13;18(12):1432-4
pubmed: 22081012
Mol Cell Biol. 2010 May;30(10):2341-52
pubmed: 20231360
Cancer Res. 1973 Aug;33(8):1829-36
pubmed: 4352739
Ann Hum Genet. 2004 Mar;68(Pt 2):93-109
pubmed: 15008789
Nat Cell Biol. 2016 May;18(5):480-90
pubmed: 27088856
Cell. 2017 Jun 1;169(6):1105-1118.e15
pubmed: 28575672
Curr Biol. 1997 Jun 1;7(6):427-39
pubmed: 9197240
Blood. 2018 May 24;131(21):e1-e11
pubmed: 29588278
Lancet. 1981 Oct 31;2(8253):982
pubmed: 6117742
J Am Chem Soc. 2011 Jun 22;133(24):9140-3
pubmed: 21604744
Blood. 2018 Feb 15;131(7):717-732
pubmed: 29146883
Nature. 2018 Jan 11;553(7687):171-177
pubmed: 29323295
J Biol Chem. 1974 Dec 10;249(23):7653-63
pubmed: 4373474
J Clin Invest. 1989 Jan;83(1):314-6
pubmed: 2562960
Anal Chem. 1998 Jun 1;70(11):2311-20
pubmed: 21644641
Nature. 2018 Sep;561(7724):473-478
pubmed: 30185910
J Natl Cancer Inst. 2009 May 20;101(10):751-61
pubmed: 19436030
Am Ind Hyg Assoc J. 1985 Jan;46(1):1-3
pubmed: 4025145
Genet Med. 2017 Jul;19(7):796-802
pubmed: 28102861
Cell. 2004 Feb 20;116(4):617-28
pubmed: 14980227
Nature. 2017 Aug 31;548(7669):549-554
pubmed: 28813411
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Nature. 2015 Apr 23;520(7548):549-52
pubmed: 25707806
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Mutat Res. 2007 Jun 15;630(1-2):78-91
pubmed: 17434794
Carcinogenesis. 2001 Jun;22(6):913-6
pubmed: 11375898
Carcinogenesis. 2001 Mar;22(3):433-9
pubmed: 11238183
J Chromatogr A. 2002 Jan 11;943(1):1-13
pubmed: 11820270
Mutat Res. 1998 Mar 30;413(3):227-34
pubmed: 9651534
Blood. 2010 Apr 22;115(16):3196-205
pubmed: 20194897
Nature. 2020 Apr;580(7805):640-646
pubmed: 32350471
Alcohol Res Health. 2007;30(1):22-7
pubmed: 17718397

Auteurs

Felix A Dingler (FA)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Meng Wang (M)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK; Department of Haematology, University of Cambridge, Cambridge, UK.

Anfeng Mu (A)

Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto University, Kyoto, Japan; Department of Genome Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Christopher L Millington (CL)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Nina Oberbeck (N)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Sam Watcham (S)

Department of Haematology, University of Cambridge, Cambridge, UK; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.

Lucas B Pontel (LB)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK; Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET, Polo Científico Tecnológico, Godoy Cruz 2390, C1425FQD Buenos Aires, Argentina.

Ashley N Kamimae-Lanning (AN)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Frederic Langevin (F)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Camille Nadler (C)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Rebecca L Cordell (RL)

Department of Chemistry, University of Leicester, Leicester LE1 7RH, UK.

Paul S Monks (PS)

Department of Chemistry, University of Leicester, Leicester LE1 7RH, UK.

Rui Yu (R)

Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, USA.

Nicola K Wilson (NK)

Department of Haematology, University of Cambridge, Cambridge, UK; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.

Asuka Hira (A)

Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto University, Kyoto, Japan; Department of Genome Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Kenichi Yoshida (K)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Minako Mori (M)

Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto University, Kyoto, Japan; Department of Genome Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yusuke Okamoto (Y)

Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto University, Kyoto, Japan; Department of Genome Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yusuke Okuno (Y)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hideki Muramatsu (H)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yuichi Shiraishi (Y)

Section of Genome Analysis Platform, Center for Cancer Genomic and Advanced Therapeutics, National Cancer Center, Tokyo, Japan.

Masayuki Kobayashi (M)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Hematology, Kyoto Katsura Hospital, Kyoto, Japan.

Toshinori Moriguchi (T)

Department of Hematology, Kyoto Katsura Hospital, Kyoto, Japan.

Tomoo Osumi (T)

Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Motohiro Kato (M)

Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Satoru Miyano (S)

Laboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, University of Tokyo, Tokyo Japan.

Etsuro Ito (E)

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Seiji Kojima (S)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hiromasa Yabe (H)

Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.

Miharu Yabe (M)

Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.

Keitaro Matsuo (K)

Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan; Division of Analytical Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Sweden; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Berthold Göttgens (B)

Department of Haematology, University of Cambridge, Cambridge, UK; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.

Michael R G Hodskinson (MRG)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Minoru Takata (M)

Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto University, Kyoto, Japan; Department of Genome Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. Electronic address: takata.minoru.8s@kyoto-u.ac.jp.

Ketan J Patel (KJ)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK. Electronic address: kjp@mrc-lmb.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH